BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20795600)

  • 1. Frequent prosthesis refitting to prevent implant exposure in patients with retinoblastoma.
    Williams BK; Schefler AC; Garonzik SN; Gologorsky D; Shi W; Cavalcante LL; Cavalcante ML; Feuer WJ; Murray TG
    J Pediatr Ophthalmol Strabismus; 2011; 48(4):238-46. PubMed ID: 20795600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exposure of primary orbital implants in postenucleation retinoblastoma patients.
    Lee V; Subak-Sharpe I; Hungerford JL; Davies NP; Logani S
    Ophthalmology; 2000 May; 107(5):940-5; discussion 946. PubMed ID: 10811087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implant and prosthesis movement after enucleation: a randomized controlled trial.
    Shome D; Honavar SG; Raizada K; Raizada D
    Ophthalmology; 2010 Aug; 117(8):1638-44. PubMed ID: 20417565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposure of orbital implants wrapped with polyester-urethane after enucleation for advanced retinoblastoma.
    Heimann H; Bechrakis NE; Zepeda LC; Coupland SE; Hellmich M; Foerster MH
    Ophthalmic Plast Reconstr Surg; 2005 Mar; 21(2):123-8. PubMed ID: 15778666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of porous polyethylene implant exposure in patients with retinoblastoma following enucleation.
    Kim JH; Khwarg SI; Choung HK; Yu YS
    Ophthalmic Surg Lasers Imaging; 2004; 35(6):446-52. PubMed ID: 15580966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orbital implants in retinoblastoma patients: 23 years of experience and a review of the literature.
    Mourits DL; Moll AC; Bosscha MI; Tan HS; Hartong DT
    Acta Ophthalmol; 2016 Mar; 94(2):165-74. PubMed ID: 26603132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Porous orbital implant after enucleation in retinoblastoma patients: indications and complications.
    Lang P; Kim JW; McGovern K; Reid MW; Subramanian K; Murphree AL; Berry JL
    Orbit; 2018 Dec; 37(6):438-443. PubMed ID: 29461921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Porous polyethylene orbital implant in patients with retinoblastoma.
    Karcioglu ZA; al-Mesfer SA; Mullaney PB
    Ophthalmology; 1998 Jul; 105(7):1311-6. PubMed ID: 9663239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free orbital fat graft to prevent porous polyethylene orbital implant exposure in patients with retinoblastoma.
    Kim NJ; Choung HK; Khwarg SI; Yu YS
    Ophthalmic Plast Reconstr Surg; 2005 Jul; 21(4):253-8. PubMed ID: 16052135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The quasi-integrated porous polyethylene implant in pediatric patients enucleated for retinoblastoma.
    Marx DP; Vagefi MR; Bearden WH; Anderson RL; Yen MT
    Orbit; 2008; 27(6):403-6. PubMed ID: 19085293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure rate of smooth surface tunnel porous polyethylene implants after enucleation.
    Mahoney NR; Grant MP; Iliff NT; Merbs SL
    Ophthalmic Plast Reconstr Surg; 2014; 30(6):492-8. PubMed ID: 25369179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the exposure rate of wrapped hydroxyapatite (Bio-Eye) versus unwrapped porous polyethylene (Medpor) orbital implants in enucleated patients.
    Tabatabaee Z; Mazloumi M; Rajabi MT; Khalilzadeh O; Kassaee A; Moghimi S; Eftekhar H; Goldberg RA
    Ophthalmic Plast Reconstr Surg; 2011; 27(2):114-8. PubMed ID: 20829725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyester 5-0 suture for porous implant placement after retinoblastoma enucleation: analysis of 120 sockets.
    Ye H; Chen R; Xiao W; Lian X; Yang H
    BMC Ophthalmol; 2023 Jan; 23(1):30. PubMed ID: 36690980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of orbital volumes in enucleated patients with unilateral retinoblastoma: hydroxyapatite implants versus silicone implants.
    Lyle CE; Wilson MW; Li CS; Kaste SC
    Ophthalmic Plast Reconstr Surg; 2007; 23(5):393-6. PubMed ID: 17881992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary orbital polymethylmethacrylate implant following primary enucleation for retinoblastoma: a study of 321 cases.
    Taneja S; Aldoais T; Kaliki S
    Orbit; 2021 Apr; 40(2):127-132. PubMed ID: 32252576
    [No Abstract]   [Full Text] [Related]  

  • 16. Hydroxyapatite orbital implant in children following enucleation: analysis of 531 sockets.
    Shah SU; Shields CL; Lally SE; Shields JA
    Ophthalmic Plast Reconstr Surg; 2015; 31(2):108-14. PubMed ID: 24896774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of enucleation and porous polyethylene orbital implant insertion in patients with paediatric retinoblastoma: a long-term follow-up study.
    Yang MK; Lee MJ; Kim N; Choung H; Khwarg SI
    Br J Ophthalmol; 2022 Apr; 106(4):502-509. PubMed ID: 33293268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxyapatite orbital implant exposure in children.
    Nolan LM; O'keefe M; Lanigan B
    J AAPOS; 2003 Oct; 7(5):345-8. PubMed ID: 14566317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orbital implants in enucleation surgery: a report by the American Academy of Ophthalmology.
    Custer PL; Kennedy RH; Woog JJ; Kaltreider SA; Meyer DR
    Ophthalmology; 2003 Oct; 110(10):2054-61. PubMed ID: 14522788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxyapatite versus polyethylene orbital implants for patients undergoing enucleation for uveal melanoma.
    Chao DL; Harbour JW
    Can J Ophthalmol; 2015 Apr; 50(2):151-4. PubMed ID: 25863856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.